News articles for Matinas BioPharma:
Monday, February 4, 2013
Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
TEWKSBURY, N.J. and TARPON SPRINGS, Fla., Feb. 4, 2013 /PRNewswire/ -- Matinas BioPharma, Inc., a biopharmaceutical company focused on the commercialization and development of omega-3-based prescription therapeutics for the treatment of metabolic and cardiovascular conditions, announced today that Roelof Rongen, Matinas BioPharma's Chief Executive Officer, is ...
read more